Abstract
The goal of our study was to prepare carboplatin niosomes for enhanced delivery to cancer cells by thin film hydration technique using (cholesterol: surfactant) in the micromolar ratio of 30:100 and with/without the addition of charge inducing agents and Pluronic F 68. Photomicrographs of the formulations show the presence of multilamellar vesicles in the forumulation with Tween 80 and Pluronic F 68. The vesicle size of the formulation was found to be in the size range of 0.01-1µm. Carboplatin niosome formulation without any charge inducing agent and Pluronic F68 shows good drug entrapment (89.24%) with an in vitro release of 87.23% in 12 hours. Drug release kinetics of the formulation follows the Non Fickian diffusion mechanism and exhibits first order release kinetics. The in vitro cytotoxicity results of the formulations reveal that the Tween 80 formulation with Pluronic shows the highest level of cytotoxicity (90%) when compared with drug in solution. Also, the stability studies of the formulations reveal that the formulations were stable in refrigerated condition.
Keywords: Carboplatin, Cancer and Niosomes, in vitro Cytotoxicity, Drug targeting, therapeutic, immunoglobulins, serum proteins, synthetic polymers, liposomes, microspheres, erythrocytes, phospholipid, nonionic surfactant, viruses.
Drug Delivery Letters
Title:Formulation and Evaluation of in vitro Cytotoxicity of Carboplatin Niosomes
Volume: 2 Issue: 3
Author(s): V. Sankar, I. R. Antony Noby, B. Ramakrishna, Elizabeth Babu, Shalini Devi Penmetsa and Sivaram Hariharan
Affiliation:
Keywords: Carboplatin, Cancer and Niosomes, in vitro Cytotoxicity, Drug targeting, therapeutic, immunoglobulins, serum proteins, synthetic polymers, liposomes, microspheres, erythrocytes, phospholipid, nonionic surfactant, viruses.
Abstract: The goal of our study was to prepare carboplatin niosomes for enhanced delivery to cancer cells by thin film hydration technique using (cholesterol: surfactant) in the micromolar ratio of 30:100 and with/without the addition of charge inducing agents and Pluronic F 68. Photomicrographs of the formulations show the presence of multilamellar vesicles in the forumulation with Tween 80 and Pluronic F 68. The vesicle size of the formulation was found to be in the size range of 0.01-1µm. Carboplatin niosome formulation without any charge inducing agent and Pluronic F68 shows good drug entrapment (89.24%) with an in vitro release of 87.23% in 12 hours. Drug release kinetics of the formulation follows the Non Fickian diffusion mechanism and exhibits first order release kinetics. The in vitro cytotoxicity results of the formulations reveal that the Tween 80 formulation with Pluronic shows the highest level of cytotoxicity (90%) when compared with drug in solution. Also, the stability studies of the formulations reveal that the formulations were stable in refrigerated condition.
Export Options
About this article
Cite this article as:
Sankar V., R. Antony Noby I., Ramakrishna B., Babu Elizabeth, Devi Penmetsa Shalini and Hariharan Sivaram, Formulation and Evaluation of in vitro Cytotoxicity of Carboplatin Niosomes, Drug Delivery Letters 2012; 2 (3) . https://dx.doi.org/10.2174/2210304x11202030223
DOI https://dx.doi.org/10.2174/2210304x11202030223 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
Call for Papers in Thematic Issues
Nanomaterial Assisted Targeted Therapies for Chronic Disorders- Preclinical to Clinical Outcomes
In recent years, the integration of nanomaterials into therapeutic strategies has emerged as a promising avenue in the pursuit of more effective treatments for chronic disorders. This dynamic field, explored in the context of "Nanomaterial Assisted Targeted Therapies for Chronic Disorders - Preclinical to Clinical Outcomes," seeks to bridge the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer
Reviews on Recent Clinical Trials Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews 1,2,4-Triazine Chemistry Part III: Synthetic Strategies to Functionalized Bridgehead Nitrogen Heteroannulated 1,2,4-Triazine Systems and their Regiospecific and Pharmacological Properties
Current Organic Synthesis Preclinical and Clinical Studies on the Use of Stem Cells for Bone Repair: A Systematic Review
Current Stem Cell Research & Therapy Hierarchy of Knowledge Translation: From Health Problems to Ad-Hoc Drug Design
Current Medicinal Chemistry Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC
Current Pharmaceutical Design Autophagy Fails to Alter Withaferin A-Mediated Lethality in Human Breast Cancer Cells
Current Cancer Drug Targets Nanocarrier based Antiretroviral Drug Delivery Approaches
Pharmaceutical Nanotechnology Role of the Autonomic Nervous System in the Tumor Micro-Environment and its Therapeutic Potential
Current Pharmaceutical Design CD133 Expressing Pericytes and Relationship to SDF-1 and CXCR4 in Spinal Cord Injury
Current Neurovascular Research Drug Resistance in Renal Tumors of Childhood
Current Pharmaceutical Biotechnology Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design An Engrossing History of Azidothymidine
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Advances of Kinesin Motor Inhibitors and their Clinical Progress
Reviews on Recent Clinical Trials Structural and Mechanistic Insights of CRAC Channel as a Drug Target in Autoimmune Disorder
Current Drug Targets State of Research Tracks and Property Protection of Photodynamic Sensitizers and Delivery Methodologies
Recent Patents on Chemical Engineering Heterogeneity in the Pathology and Molecular Biology of Breast Cancer
Current Genomics Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical Pharmacology
Current Drug Metabolism Role of Cytomegalovirus in Salivary Gland Tumors: An Unfolded Mystery
Recent Patents on Biomarkers Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report
Current Medical Imaging